New Pfizer Covid Pill Could Be a Gamechanger for Biotech ETFs

by | Mar 24, 2021 | BioTech Stocks, Outside Takes, Tech Stocks

This is originally from post published on on ETFTrends.com.

Although there is significant optimism surrounding the coronavirus vaccine rollout, recent developments show that 21 states are actually experiencing an increase in infections, generating concern among researchers and government leaders. To that end, Pfizer announced Tuesday it has commenced an early stage clinical trial of an experimental oral antiviral drug for the coronavirus. The New […]

The post New Pfizer Covid Pill Could Be a Gamechanger for Biotech ETFs appeared first on ETF Trends.


This is originally from post published on on ETFTrends.com.

>

Pin It on Pinterest

Share This